Caspofungin
| Recommendation | Insufficient data |
|---|---|
| Comments | Accumulating data suggest reduced echinocandin exposure in obesity, but evidence for the ideal dose adjustment strategy is limited (Am J Health Syst Pharm 2023;80:503). A weight-based regimen (2 mg/kg load, 1.25 mg/kg q24h) has been suggested (AAC 2020;64:e00905-20). |